[Cryptogenic anti-8 inhibitor].
D001379:Azathioprine / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D001778:Blood Coagulation Disorders / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D002763:Cholecystectomy; D004438:Ecchymosis / Q000209:etiology; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D005340:Fibrinogen / Q000032:analysis; D006395:Hemarthrosis / Q000209:etiology; D006406:Hematoma / Q000209:etiology; D006470:Hemorrhage / Q000209:etiology; D006474:Hemorrhagic Disorders / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous
D005169:Factor VIII; D005340:Fibrinogen; D001379:Azathioprine; D011241:Prednisone
Inhibiteur anti-8 cryptogénique.